By Dr. Brandon Bright, DAOM, LAc · Doctor of Acupuncture & Oriental Medicine · Functional Medicine University-certified · Tustin, CA · Last reviewed: August 10, 2026
On August 6, Hims & Hers launched a new Hers app billed as a “doctor-led, AI-native care experience” — rolling out first to weight-loss members, with a free connected smart scale that syncs your weight and GLP-1 progress to the app, your care team, and an AI layer trained on clinical protocols. Free hardware is a genuinely compelling offer, and the product itself looks well-built. But “free” in consumer health always has a structure behind it, and two weeks before this launch, the FTC and several states sued Hims’s parent company over how member health data was handled. If you’re a woman considering the new Hers app — or anyone watching where AI-powered telehealth is going — here’s the honest breakdown of what you get and what you give.
The 55-second answer
The free scale is real and the app is a real product: continuous weight sync, AI-shaped check-ins, provider oversight, GLP-1 progress tracking. What you’re trading: a continuous stream of your body data into a subscription funnel whose business model is keeping you subscribed, an “AI-native” care layer that is protocol-driven chat rather than a clinician who knows you, and enrollment in a data ecosystem that is — at this writing — the subject of an unresolved FTC lawsuit alleging health data was shared with advertising platforms. None of that makes the offer a scam. It makes it a trade. Take the trade with open eyes if the convenience tier fits your needs; understand what the next tier up looks like if it doesn’t.
What you actually get (credit where due)
The offer is genuinely strong on its own terms:
- A free connected smart scale — comparable hardware retails for $50–$100. It syncs automatically; no manual logging.
- Continuous progress visibility — your weight trend, GLP-1 milestones, and check-in data in one interface, visible to you and your care team.
- AI-shaped support between visits — responses informed by clinical weight-loss protocols, available on demand, no appointment needed.
- Provider oversight — licensed clinicians review flagged data and manage the prescription layer.
For a straightforward case — a member on a GLP-1 who wants low-friction tracking and quick answers — this is a real improvement over the previous experience, and it’s ahead of most telehealth competitors on engagement design. The stock jumped on the launch for a reason.
Trade #1: your body data becomes a continuous stream
A connected scale changes the data relationship. Before: you told your provider your weight at appointments. Now: a sensor in your bathroom reports your body composition to a company’s cloud daily.
The timing here matters. On July 29 — eight days before this launch — the FTC and several state attorneys general sued Hims & Hers, alleging among other things that member health information was shared with third-party advertising platforms (Meta and Snap were named in reporting) without adequate consent. To be fair and precise: these are allegations; the case is unresolved; Hims disputes the claims. Nothing has been proven, and I make no claim about the outcome.
But you don’t need a verdict to draw the practical lesson: when a company’s growth engine is a subscription funnel, your data is an asset in that funnel, and the incentives around it deserve your attention before you connect a daily body-data stream. Questions worth answering before you step on the scale: What does the privacy policy permit? Can you use the app with data-sharing minimized? What happens to your data if you cancel? (I walked through the broader telehealth-privacy landscape — including this lawsuit — in the telehealth data privacy piece.)
Trade #2: “AI-native care” is a funnel with a clinician attached — not a clinician with tools attached
This is the distinction that matters most clinically, and it’s subtle because both models can describe themselves with the same words (“doctor-led,” “AI-powered,” “personalized”).
AI-in-a-funnel: the AI is the primary interface. It’s trained on protocols, it handles your questions, it escalates exceptions. The clinician exists behind the system — reviewing flags, signing prescriptions, managing by exception across a very large panel. The economics require it: the model works because most member interactions never need a human. It’s efficient, scalable, and fine for routine cases. But the system’s job is to keep you moving through the protocol — and subscribed.
Clinician-in-the-loop: a named clinician who knows your case is the primary relationship. AI and data tools serve that clinician’s interpretation — surfacing patterns, organizing data, extending their reach between visits. The accountable party is a person whose name you know, whose license is on the line, and who you can actually ask “what would you do if I were your family member?”
Neither model is dishonest. They’re different products at different price points. The problem is only that the first is increasingly marketed in the language of the second. When the AI-native app tells you it’s “doctor-led,” the useful question is: can you name your doctor, and does your doctor know your name?
Trade #3: the scale measures the number that matters least
A clinical point that has nothing to do with Hims specifically: daily scale weight is the noisiest, least informative metric in weight management — and building an engagement loop around it has costs.
On a GLP-1, the numbers that actually determine whether your outcome lasts are body composition (are you losing fat or muscle?), protein intake, resistance-training consistency, sleep, and metabolic markers. A scale-centered app experience trains attention on daily gross weight — which fluctuates 2–4 pounds on water and glycogen alone, and which can look “great” while muscle loss is quietly wrecking your long-term metabolic rate. Rapid scale-weight loss with inadequate protein and no resistance training is the classic GLP-1 failure pattern: the number goes down, the rebound risk goes up. (The GLP-1 decision framework covers the full protocol; the women’s hormones intersection covers what the scale won’t tell women in the perimenopausal decade.)
A free scale that deepens daily weight fixation is not a neutral gift. Use it as trend data (weekly average, not daily readings) and pair it with the measures that matter — or it manages you.
Who the offer genuinely fits — and who should skip it
Take the trade if: you’re an existing or prospective Hers weight-loss member with a routine case, you want low-friction tracking, you’ve read the privacy settings and you’re comfortable with the data relationship, and you have your own protein/resistance/sleep protocol running (because the app won’t build one for you).
Think harder if: your case is complex (perimenopause, thyroid history, disordered-eating history — where daily-weight engagement loops can do real harm), you’re privacy-sensitive about body data, or you’ve noticed that subscription-funnel medicine keeps answering your questions without ever quite knowing you.
The alternative tier isn’t “no technology” — it’s technology in service of a named clinician. At the Tustin practice, GLP-1 patients get the labs, the body-composition tracking, the protein and resistance-training protocol, and a clinician who knows their case and answers for the plan — cash/HSA/FSA, $199 first visit, superbill for out-of-network reimbursement. The trade runs the other way: you pay directly, and the incentive structure points at your outcome rather than your retention.
Frequently asked questions
Is the free scale actually free? No hidden hardware charge has been reported — it’s an acquisition/retention cost for the membership. “Free with subscription” is the accurate framing.
Is the Hers AI app dangerous? No evidence suggests that. The clinical concern isn’t danger — it’s the gap between marketed personalization and the by-exception reality, plus the data relationship. It’s a legitimate convenience tier.
Did Hims actually sell health data? Unresolved. The FTC and state AGs allege improper sharing with ad platforms; Hims disputes it; no court has ruled. Read the full privacy breakdown and make your own call.
Can I use the app but not the scale? Based on the launch materials, the scale is a benefit, not a requirement. Skipping the connected hardware reduces the data stream considerably.
What should I weigh instead of daily weight? Weekly average weight, waist measurement, body composition every 1–3 months (DEXA or InBody), strength progression, and how clothes fit. Daily gross weight is noise.
Does this change anything if I’m already a happy Hims/Hers member? Not necessarily. Check your privacy settings, use the scale as weekly-trend data, and make sure the protocol layer (protein, resistance training, sleep) exists somewhere in your life — the app won’t supply it.
What to do this week
If you’re taking the offer: read the privacy policy before pairing the scale, set your sharing preferences deliberately, and decide now that you’ll read weekly trends, not daily readings.
If the funnel tier has been leaving your questions half-answered: book a first visit at the Tustin practice — $199 in person, $150 virtual. A named clinician, your full picture, and a plan someone actually answers for.
If you want the data-privacy context first: read the telehealth privacy piece.
If you’re earlier in the decision — whether a GLP-1 is even right for you: start with the decision framework.
Dr. Brandon Bright is a Doctor of Acupuncture and Oriental Medicine (DAOM), Licensed Acupuncturist in California, and Functional Medicine University-certified. He runs a multi-modality holistic medicine practice at 13732 Newport Ave STE 2, Tustin, CA 92780. Phone: 714-206-7883. He has no financial relationship with Hims & Hers or any telehealth company. He is not a medical doctor and does not prescribe GLP-1 medications. The FTC lawsuit described in this article is an unresolved legal allegation, not a finding of wrongdoing. This article is educational and not a substitute for individualized medical advice.
Related reading
- How to Talk to Your Conventional Doctor About Your Functional Medicine Findings (Without the Conversation Going Sideways)
- Steps to Stay Smoke-Free
- Hims & Hers Just Bought Eucalyptus for $1.15B — Here’s What It Means If You’re a Patient (or Considering Becoming One)
- What Is Adrenal Fatigue and What Can You Actually Do About It? The Eastern and Western View